CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fagron NV is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fagron NV
Venecoweg 20A
Phone: +32 80012880p:+32 80012880 NAZARETH, 9810  Belgium Ticker: FAGRFAGR
Business Summary
Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. The Company specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. It operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202412/31/2023Yes---Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Representing AHOK BV KoenHoffman 56 5/8/2017 5/8/2017
Chief Executive Officer, Executive Director RafaelPadilla 42 1/1/2018 1/1/2017
Chief Financial Officer, Executive Director Karinde Jong 41 5/8/2017 5/1/2016
9 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Letco Medical LLC 1316 Commerce Drive NW Decatur AL United States
FREEDOM PHARMACEUTICALS 801 W NEW ORLEANS ST BROKEN ARROW OK US
Humco Holding Group, Inc. 7400 Alumax Drive Texarkana TX United States

Business Names
Business Name
0HNZ
All Chemistry
Arseus NV
7 additional Business Names available in full report.

General Information
Number of Employees: 3,460 (As of 12/31/2023)
Outstanding Shares: 72,986,905 (As of 6/30/2024)
Stock Exchange: EBR
Fax Number: +32 92162491


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024